Biased Multicomponent Reactions to Develop Novel Bromodomain Inhibitors

DSpace/Manakin Repository

Biased Multicomponent Reactions to Develop Novel Bromodomain Inhibitors

Citable link to this page

 

 
Title: Biased Multicomponent Reactions to Develop Novel Bromodomain Inhibitors
Author: McKeown, Michael R; Shaw, Daniel L; Fu, Harry; Liu, Shuai; Xu, Xiang; Marineau, Jason J; Huang, Yibo; Zhang, Xiaofeng; Buckley, Dennis L; Kadam, Asha; Zhang, Zijuan; Blacklow, Stephen C; Qi, Jun; Zhang, Wei; Bradner, James E

Note: Order does not necessarily reflect citation order of authors.

Citation: McKeown, M., D. L. Shaw, H. Fu, S. Liu, X. Xu, J. J. Marineau, Y. Huang, et al. 2014. “Biased Multicomponent Reactions to Develop Novel Bromodomain Inhibitors.” Journal of Medicinal Chemistry 57 (21): 9019-9027. doi:10.1021/jm501120z. http://dx.doi.org/10.1021/jm501120z.
Full Text & Related Files:
Abstract: BET bromodomain inhibition has contributed new insights into gene regulation and emerged as a promising therapeutic strategy in cancer. Structural analogy of early methyl-triazolo BET inhibitors has prompted a need for structurally dissimilar ligands as probes of bromodomain function. Using fluorous-tagged multicomponent reactions, we developed a focused chemical library of bromodomain inhibitors around a 3,5-dimethylisoxazole biasing element with micromolar biochemical IC50. Iterative synthesis and biochemical assessment allowed optimization of novel BET bromodomain inhibitors based on an imidazo[1,2-a]pyrazine scaffold. Lead compound 32 (UMB-32) binds BRD4 with a Kd of 550 nM and 724 nM cellular potency in BRD4-dependent lines. Additionally, compound 32 shows potency against TAF1, a bromodomain-containing transcription factor previously unapproached by discovery chemistry. Compound 32 was cocrystallized with BRD4, yielding a 1.56 Å resolution crystal structure. This research showcases new applications of fluorous and multicomponent chemical synthesis for the development of novel epigenetic inhibitors.
Published Version: doi:10.1021/jm501120z
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234447/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:23474045
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters